Posts With Tag NASDAQ MBRX

Explore Moleculin Biotech's latest 8-K filing dated February 13, 2025. Key insights on stock, SEC compliance, and potential impacts for investors.

Discover Moleculin Biotech's 8-K report filed on February 9, 2025. Key insights on stock info, corporate changes, and contact details for MBRX on NASDAQ.

Explore Moleculin Biotech, Inc.'s SEC Form 8-K filed on February 11, 2025, detailing significant corporate events impacting MBRX stock and investor insights.

Discover significant updates from Moleculin Biotech, Inc. in their January 8, 2025, 8-K filing. Stay informed on corporate changes and market impact.

Explore Moleculin Biotech, Inc.'s latest 8-K filing revealing significant events. Stay informed on MBRX's SEC compliance and operational updates from Houston, TX.